10 completed, 1 active not recruiting. 11 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 10, Active not recruiting 1 |
Follow Cervarix: new trials by email Literature Review of Cervarix trials Research Report on Cervarix
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Single Dose of Cervarix Vaccine in Girls or Three Doses of Gardasil Vaccine in Women for the Prevention of Human Papillomavirus Infection, the PRIMAVERA-ESCUDDO Trial Quadrivalent Human Papillomavirus (types 6, 11, 16, 18) Recombinant Vaccine, Recombinant Human Papillomavirus Bivalent Vaccine - Human Papillomavirus-Related Cervical Carcinoma | Phase 3 | Completed | National Cancer Institute (NCI) | 1240 | 2019-04-01 | 2025-08-03 |
| A Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls bivalent HPV vaccine, nonavalent HPV vaccine - Human Papilloma Virus | Phase 3 | Active not recruiting | London School of Hygiene and Tropical Medicine | 930 | 2017-02-23 | 2026-09-08 |
| Safety and Immunogenicity of GSK Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) in Healthy Female Children 4-6 Years Old Cervarix, Priorix, Infanrix - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 148 | 2012-10-15 | 2020-04-10 |
| Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females Cervarix, Gardasil, Placebo - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 1079 | 2011-11-21 | 2019-11-15 |
| Gynaecological Follow-up of a Subset of HPV-015 (NCT00294047) Study Subjects Gynaecological follow-up, Cervarix, Placebo control - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 34 | 2011-09-12 | 2019-10-30 |
| Evaluation of Immunogenicity and Safety of Two 2-dose Human Papillomavirus (HPV) Vaccine Schedules in 9-14 Year Old Girls GSK Biologicals' HPV vaccine 580299 - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 1447 | 2011-06-29 | 2020-06-09 |
| Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects. Cervarix - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 92 | 2009-05-01 | 2016-10-20 |
| Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine (GSK580299) in Healthy Female Subjects 10-25 Years of Age. Cervarix, Placebo Al(OH)3 - Human Papillomavirus (HPV) Infection | Phase 3 | Completed | GlaxoSmithKline | 676 | 2007-10-01 | 2020-11-17 |
| Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM), Gardasil ® (Merck & Co. Inc), Placebo - Infections, Papillomavirus, Papillomavirus Vaccines | Phase 3 | Completed | GlaxoSmithKline | 1106 | 2007-01-24 | 2020-01-02 |
| Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older Cervarix, Placebo control - Infections, Papillomavirus, Papillomavirus Vaccines | Phase 3 | Completed | GlaxoSmithKline | 5752 | 2006-02-16 | 2020-01-02 |
| Human Papilloma Virus (HPV) Vaccine Immunogenicity and Safety Trial in Young and Adult Women With GSK Biologicals' HPV-16/18 Cervarix - Infections, Papillomavirus | Phase 3 | Completed | GlaxoSmithKline | 667 | 2004-10-07 | 2019-12-11 |
Papillomavirus Infections (9) · Uterine Cervical Neoplasms (5) · Infections (1) · Virus Diseases (1)
GlaxoSmithKline (9) · London School of Hygiene and Tropical Medicine (1) · National Cancer Institute (NCI) (1)
Canada (3) · Singapore (3) · United States (3) · Germany (2) · Hong Kong (2) · Mexico (2) · Netherlands (2) · Portugal (2) · Russia (2) · Tanzania (2) · Thailand (2) · United Kingdom (2) · Australia (1) · Colombia (1) · Costa Rica (1)
Aimee R Kreimer (1) · Deborah Watson-Jones, Dr (1)
PMID 41276263, PMID 24731816, PMID 25208608, PMID 26685704, PMID 31273942, PMID 31824976, PMID 33421649, PMID 36113531, PMID 36113532, PMID 36460537, PMID 38365419, PMID 39890232, PMID 41419735, PMID 42378813
2004 (1), 2005 (1), 2009 (1), 2017 (1)